Strona internetowa Xenico Pharma została oparta o indywidualny szablon strony. Strona www została wdrożona do systemu zarządzania treścią (CMS) WordPress.

For the fiscal year ended May 31, 2005, revenues increased 12 percent to $13.7 billion, compared to $12.3 billion in fiscal year 2004. Changes in currency exchange rates contributed three percentage points of this growth, while the acquisition of Converse and Starter added one point. Full year net income was up 28 percent to $1.2 billion, or $4.48 per diluted share, versus $945.6 million, or $3.51 per diluted share, in 2004.

Klient

Xenico Pharma

Typ

Strona internetowa

Inne projekty